Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Design next-gen clinical trials with data and AI

13 October 2026 · By · Wire by Fusion42

Published

13 October 2026

Topic

opportunities

◆ Sectors

Digital HealthAI InfrastructureData & Analytics

◆ Source

Read at salesforce.com →

◆ Verified

Fusion42 · 13 October 2026 · Fusion42 review

Next-generation clinical trials are being redesigned using data and AI technologies to overcome barriers like complex documentation, manual processes, and regulatory hurdles, aiming to improve trial design, site selection, and patient recruitment and retention.

This Wire brief sits within Fusion42's coverage of Digital Health, AI Infrastructure and Data & Analytics.

◆ ◆ The Wire takeaway

You can now reshape clinical trials beyond digitisation by embedding AI directly into trial design and patient matching. This opens a fast path to reduce costs and speed therapies to market, making patient recruitment your strongest lever.

◆ Coverage

1 source · 13 Oct 2026

◆ Related on Wire

◆ Topics

Digital HealthAI InfrastructureData & Analyticsclinical-trialsdata-aihealthtechpatient-recruitmenttrial-design